PAGE TITLE

Rick Fair is the CEO of Enliven Pharmaceuticals and has over 25 years of leadership experience in the biopharmaceutical industry. Before Enliven, he was the Chief Executive Officer of Bellicum Pharmaceuticals, Inc., a biotech focused on developing cellular therapies for cancer. Before that, he held commercial leadership positions at Genentech/Roche and Johnson & Johnson. Rick has a MBA from Columbia University and a BS from the University of Michigan.

‍